HMMR and precursor B-cell acute lymphoblastic leukemia: Since HMMR mRNA expression could be a tool for the early prognosis of B-ALL patients, we evaluated HMMR expression at the protein level in the peripheral blood of 54 control samples (Figure 4A) and 63 B-ALL patients (Figure 4B).